280 related articles for article (PubMed ID: 30604161)
1. Preoperative predictive factors focused on inflammation-, nutrition-, and muscle-status in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomy.
Itami Y; Miyake M; Tatsumi Y; Gotoh D; Hori S; Morizawa Y; Iida K; Ohnishi K; Nakai Y; Inoue T; Anai S; Tanaka N; Shimada K; Hirao S; Fujimoto K
Int J Clin Oncol; 2019 May; 24(5):533-545. PubMed ID: 30604161
[TBL] [Abstract][Full Text] [Related]
2. Integrative Assessment of Pretreatment Inflammation-, Nutrition-, and Muscle-Based Prognostic Markers in Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy.
Miyake M; Morizawa Y; Hori S; Marugami N; Iida K; Ohnishi K; Gotoh D; Tatsumi Y; Nakai Y; Inoue T; Anai S; Torimoto K; Aoki K; Tanaka N; Shimada K; Konishi N; Fujimoto K
Oncology; 2017; 93(4):259-269. PubMed ID: 28647740
[TBL] [Abstract][Full Text] [Related]
3. Preoperative prognostic nutritional index is a significant predictor of survival in patients with localized upper tract urothelial carcinoma after radical nephroureterectomy.
Huang J; Yuan Y; Wang Y; Chen Y; Kong W; Xue W; Chen H; Zhang J; Huang Y
Urol Oncol; 2017 Dec; 35(12):671.e1-671.e9. PubMed ID: 28826702
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.
Shao Y; Li W; Wang D; Wu B
World J Surg Oncol; 2020 Oct; 18(1):273. PubMed ID: 33097052
[TBL] [Abstract][Full Text] [Related]
5. Significance of multiple preoperative laboratory abnormalities as prognostic indicators in patients with urothelial carcinoma of the upper urinary tract following radical nephroureterectomy.
Nishikawa M; Miyake H; Kurahashi T; Fujisawa M
Int J Clin Oncol; 2018 Feb; 23(1):151-157. PubMed ID: 28856495
[TBL] [Abstract][Full Text] [Related]
6. A critical prognostic analysis of neutrophil-lymphocyte ratio for patients undergoing nephroureterectomy due to upper urinary tract urothelial carcinoma.
Altan M; Haberal HB; Akdoğan B; Özen H
Int J Clin Oncol; 2017 Oct; 22(5):964-971. PubMed ID: 28600686
[TBL] [Abstract][Full Text] [Related]
7. Combination of Platelet-Lymphocyte Ratio and Monocyte-Lymphocyte Ratio as a New Promising Prognostic Factor in Upper Tract Urothelial Carcinoma With Large Tumor Sizes > 3 cm.
Jan HC; Hu CY; Yang WH; Ou CH
Clin Genitourin Cancer; 2020 Aug; 18(4):e484-e500. PubMed ID: 32199741
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of preoperative plasma fibrinogen level and platelet-to-lymphocyte ratio (F-PLR) in patients with localized upper tract urothelial carcinoma.
Huang J; Yuan Y; Wang Y; Zhang J; Kong W; Chen H; Chen Y; Huang Y
Oncotarget; 2017 May; 8(22):36761-36771. PubMed ID: 27901490
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Role of Neutrophil-to-lymphocyte Ratio-based Markers During Pre- and Postadjuvant Chemotherapy in Patients With Advanced Urothelial Carcinoma of Upper Urinary Tract.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Clin Genitourin Cancer; 2017 Aug; 15(4):e633-e643. PubMed ID: 28174011
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
BJU Int; 2015 Apr; 115(4):587-94. PubMed ID: 24947340
[TBL] [Abstract][Full Text] [Related]
11. The Predictive Value of Preoperative High-Sensitive C-Reactive Protein/Albumin Ratio in Systemic Inflammatory Response Syndrome After Percutaneous Nephrolithotomy.
Xu H; Hu L; Wei X; Niu J; Gao Y; He J; Hou J
J Endourol; 2019 Jan; 33(1):1-8. PubMed ID: 30430854
[TBL] [Abstract][Full Text] [Related]
12. What is the Role of the Preoperative Blood-Based Inflammation Biomarkers in the Prognosis of Upper Tract Urothelial Carcinoma With Radical Nephroureterectomy? A Single-Centre Retrospective Study.
Luo Z; Jiao B; Huang T; Zhao H; Zhang G
Technol Cancer Res Treat; 2022; 21():15330338221095667. PubMed ID: 35585719
[No Abstract] [Full Text] [Related]
13. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
[TBL] [Abstract][Full Text] [Related]
14. The neutrophil-to-lymphocyte ratio as a predictor of intravesical recurrence in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
Kishimoto N; Takao T; Kuribayashi S; Yamamichi G; Nakano K; Kawamura M; Tsutahara K; Tanigawa G; Yamaguchi S
Int J Clin Oncol; 2017 Feb; 22(1):153-158. PubMed ID: 27614622
[TBL] [Abstract][Full Text] [Related]
15. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
[TBL] [Abstract][Full Text] [Related]
16. Combination of the Preoperative Systemic Immune-Inflammation Index and Monocyte-Lymphocyte Ratio as a Novel Prognostic Factor in Patients with Upper-Tract Urothelial Carcinoma.
Jan HC; Yang WH; Ou CH
Ann Surg Oncol; 2019 Feb; 26(2):669-684. PubMed ID: 30374917
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of preoperative systemic inflammation markers in localized upper tract urothelial cell carcinoma: a large, multicenter cohort analysis.
Son S; Hwang EC; Jung SI; Kwon DD; Choi SH; Kwon TG; Noh JH; Kim MK; Seo IY; Kim CS; Kang SG; Cheon J; Ha HK; Jeong CW; Ku JH; Kwak C; Kim HH
Minerva Urol Nefrol; 2018 Jun; 70(3):300-309. PubMed ID: 29381018
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
[TBL] [Abstract][Full Text] [Related]
19. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer.
Toyokawa T; Muguruma K; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Yashiro M; Ohira M
BMC Cancer; 2020 Jun; 20(1):517. PubMed ID: 32493247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
